Skip to main content
AmigoFish

Jefferies London 2026: Protagonist Therapeutics' CEO Dinesh Patel discusses the launch of ICOTYDE, and the company's pipeline, which is well funded now due to commercial success

From BiotechTV - News · · 11 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

He comments on the early days of JNJ's ICOTYDE launch, developing an optimized IL-17, the obesity space, and more.

Back to BiotechTV - News · Report a problem